The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision ...

The Sydney funnel-web spider has extremely dangerous venom, but according to a new study this spider is actually three different species — one of which, the "Newcastle big boy," is much larger.

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

Professor Emeritus, I M Dharmadasa Sheffield Hallam University, UK This article summarises the history of solar energy ...

Inhibition of group IVA cytosolic phospholipase A2 (cPLA2α) is a potential approach for cancer treatment. Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound ...

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo, in an increasingly competitive market. Verquvo has been approved to reduce risk of ...

Governor of the Central Bank of Sri Lanka Dr. Nandalal Weerasinghe has said combating money laundering and countering financing of terrorism will help improve the credibility of the financial system, ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...